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http://dx.doi.org/10.1016/j.pedneo.2Studies in preterm infants have shown that prolonged treatment with topical iodine (multiple
doses, often over multiple days) can transiently suppress thyroid function. However, it is
uncertain if topical iodine exposure for very short periods of time can cause significant changes
in thyroid function. We report two cases of transient hypothyroidism in preterm infants after
short-term exposure to topical iodine during surgical preparation, and review their clinical and
laboratory findings before and after iodine exposure. We conclude that premature infants are
at risk of developing transient hypothyroidism in response to a single, short-term exposure to
topical iodine, even in iodine-sufficient geographical areas. We advise monitoring of thyroid
function in these infants after iodine exposure, as treatment with levothyroxine may be
needed for a limited duration to prevent the sequelae of untreated hypothyroidism. Consider-
ation of using alternative cleansing agents is also advised.
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Transient hypothyroidism after topical iodine 1291. Introduction to the abdomen and chest for 90 minutes. All iodine wasTransient neonatal hypothyroidism occurs at higher rates in
areas of iodine deficiency,1e3 as well as in infants whose
mothers are exposed to large amounts of iodine during
pregnancy, at the time of delivery or during lactation.4e8
Prior studies of preterm infants have shown that pro-
longed treatment with topical iodine (multiple doses,
usually over multiple days) can transiently suppress thyroid
function.9e13 However there is still uncertainty as to
whether topical iodine exposure for very short periods of
time can cause significant changes in thyroid function in
premature infants, with some studies suggesting that such
exposure does not alter thyroid-stimulating hormone (TSH)
in infants born in iodine-replete areas.14,15 We report two
cases of transient hypothyroidism in preterm infants, both
born in iodine-replete areas, with a significant rise in TSH
after short-term exposure to iodine during surgical
preparation.
2. Case Reports
2.1. Case 1
A 27-week estimated gestational age (EGA) female with
multiple congenital anomalies including tracheo-
esophageal (TE) fistula with esophageal atresia had initial
newborn screening tests at 48 hours that showed a low total
T4 of 68.2 nmol/L but a normal TSH of 1.9 uIU/mL. Repair of
the TE fistula and gastrostomy-tube placement was per-
formed the next day. The infant was exposed to 10%
povidone-iodine solution (Betadine) applied topically to the
abdomen and chest for 2.5 hours for surgical preparation.
A second newborn screening test obtained on Day 12 of
life revealed hypothyroidism, with a subsequent confirma-
tory serum sample showing a TSH > 150 uIU/mL and free T4
(FT4) of 3.86 pmol/L. Treatment was started with levo-
thyroxine, and 7 days later, the TSH normalized. Treatment
was ultimately discontinued by 10 weeks of age.
2.2. Case 2
A 32-week EGA female was found prenatally to have
a congenital diaphragmatic hernia (CDH) and resulting
hydrops. Initial newborn screening tests obtained at 48
hours showed a low total T4 of 34.8 nmol/L with a TSH of
10 uIU/mL. Open repair of the diaphragmatic hernia was
performed on Day 5 of life, where the infant was exposed to
10% povidone-iodine solution (Betadine) applied topicallyTable 1 Laboratory values throughout the clinical course.
Birth
weight (g)
EGA
(wk)
TSH (uIU/mL)/T4 (nmol/L)
On first newborn
screen
On second newbo
screen
Case 1 916 27 þ 6 1.9/68.2 39.8/18.0
Case 2 2300 32 þ 0 10/34.8 287/13.5
EGA Z estimated gestational age; FT4 Z free T4; QD Z once daily; Tpromptly removed after completion of the surgery.
Follow-up newborn screening tests performed at
2 weeks of age, 8 days after surgery, demonstrated
hypothyroidism. Subsequent confirmatory serum testing
showed a TSH of 391 uIU/mL and FT4 of 1.42 pmol/L.
Treatment with levothyroxine rapidly normalized the TSH
within 2 weeks. Thyroid ultrasound confirmed a normal
location and size for the thyroid gland. Because of the
patient’s age, it was decided to continue treatment with
25 mg levothyroxine daily with close follow-up of her
thyroid function tests.
A detailed time course of laboratory results, treatment
doses and demographic information for both patients are
summarized in Table 1.
3. Discussion
Exposure to exogenous iodine induces a reflexic response
in the thyroid axis of the preterm infant via the
WolffeChaikoff effect. This effect, a protective autor-
egulatory mechanism that inhibits formation of thyroid
hormone in response to elevated levels of circulating iodide,
typically resolves in a few days to weeks.10 This most often
occurs in response to oral iodine treatment or parenteral
exposure from contrast agents and is not usually a cause of
concern for patients exposed only to topical iodine.
Povidone-iodine solution is a commonly used topical
antiseptic and is very effective in preventing infection.
Although repeated exposure to topical iodine (repeated
applications continued for greater than a few days) have
been reported to alter thyroid function in premature neo-
nates,9e13 it is still unclear if short-term or even a single
exposure to topical iodine can significantly alter thyroid
function in this population. Premature infants have a very
thin epidermis that may result in greater iodine absorption
and a thyroid axis that is very sensitive to the inhibitory
effects of iodine overload. These features result in delayed
escape of inhibition of thyroid hormone synthesis,
increasing the likelihood of exogenous iodine toxicity.16
Although prior studies have examined this issue, there is
still considerable uncertainty surrounding the frequency
and duration of iodine exposure necessary to cause hypo-
thyroidism in this population. A prospective study in Italy,
which is a relatively iodine-deficient area, showed that if
topical iodine is left on the skin of very-low-birth-weight
infants at the site of minor procedures and is not cleaned
off until routine cleaning of the infant is done later, then
the TSH can rise to as high as 60 uIU/mL.17 A similar study
showed that routine use of iodine for procedures such asTSH (uIU/mL)/FT4 (pmol/L) Therapy
rn Confirmatory
labs
Shortly after initiating
treatment
>150/3.86 1.0/19.3 Stopped at 10 wk
391/1.42 1.5/28.3 25 mg QD
SH Z thyroid-stimulating hormone.
130 J.E. Pinsker et alinsertion of intravenous lines and blood gas determination
can cause TSH to rise to as high as 20 uIU/mL, but the
precise duration of iodine exposure for each infant affected
in this study was not reported.18 In contrast, a prospective
study by Brown et al disputed this finding, showing that
although urinary iodine excretion was increased in prema-
ture infants exposed to topical iodine for skin cleaning prior
to routine procedures, serum TSH did not rise, presumably
because the North American population studied was iodine-
sufficient.14 Two other studies have also shown that
increased urinary iodine concentration was not linked to
transient neonatal hypothyroidism.15,19 Unfortunately, the
issue of iodine sufficiency during pregnancy has not been
resolved, and in fact, recent reports show that inadequate
iodine intake during pregnancy is increasing in many parts
of the world, potentially putting the newborns of these
mothers at risk for transient hypothyroidism as a result of
maternal iodine deficiency.20
Premature infants are not the only population at risk of
hypothyroidism secondary to iodine exposure. Term
neonates can also show a rise in TSH when exposed to large
amounts of iodine, as has been reported in infants under-
going cardiac catheterization and surgical repair for
congenital heart disease. These infants are exposed to both
intravenous iodinated contrast studies and topical iodine,
with some infants needing treatment with levothyroxine for
up to 10 months.21
In our cases described above, we found that topical
exposure to iodine for only 90e150 minutes, which was
immediately cleaned off at the completion of the proce-
dure, was enough to cause a rise in TSH to nearly 400 uIU/
mL in premature infants who did not have elevation of TSH
on their initial thyroid screening tests. In both cases, the
infants were undergoing surgery that required a large field
of preparation.
We feel it is important to report these findings for two
reasons. First, while primary hypothyroidism has been re-
ported in patients with CDH and in patients with esophageal
atresia,22e24 our patients show that a single exposure to
topical iodine may be associated with transient hypothy-
roidism and that active surveillance is required in order to
discover and properly manage this condition. Premature
infants are at high risk of neuro-developmental delays for
multiple reasons, and every effort should be made to
decrease potential contributing factors. One could argue
that the acquired hypothyroidism was transient, and may
have been relatively brief, with little impact. However, in
both of these cases, the rise in TSH was quite robust (391
and >150 uIU/mL, respectively), suggesting that the
reduced levels of thyroid hormone could have had negative
consequence on neurocognitive outcome.25 Had these
findings not been discovered by mandated repeated
newborn screening because of the initial low T4 values
commonly seen in preterm infants, they may have remained
untreated for an extended period of time. In areas of the
USA, or other parts of the world, where repeat newborn
screening is not mandatory, increased vigilance to follow
serial thyroid function testing for infants exposed to topical
iodine is suggested in an effort to identify and initiate
thyroid hormone replacement as quickly as possible.
Second, these cases highlight that consideration should
be given to reducing the amount of iodine used duringprocedures on premature infants. Alternative agents
are available, such as the alcohol-based cleansers
2% chlorhexidine gluconate and 70% isopropyl alcohol
(ChloraPrep) and 4% chlorhexidine gluconate and 4%
isopropyl alcohol (Hibiclens). In adults, these alcohol-based
cleansing agents have been shown to be more efficacious in
reducing postoperative infections.26 However, in premature
infants, these agents must be used cautiously because of
the increased risk of systemic absorption and skin irritation.
In addition, these agents are more transparent and the
extent of preparation may not be easily visualized, poten-
tially putting the patient at a risk for infection or toxicity.
Both infants described above were born in an iodine-
sufficient region of the world and were in neonatal intensive
care units that use alcohol-based cleansers, not iodine, for
routine skin cleaning. They were not exposed to iodine for
wound care, nor did they receive any significant exposure to
topical iodine from other procedures. However, when they
were brought to the operating room for their procedure,
iodine preparation was used. From this, we conclude that
preterm infants who are exposed to topical iodine over
a large area may be at risk of developing transient hypothy-
roidism, even after a single exposure. We advise monitoring
of thyroid function in these infants, as this may lead to early
treatment and prevention of the potential sequelae of
untreated hypothyroidism. Once treatment is initiated,
thyroid function must be followed closely to ensure that
thyroid hormone replacement therapy is stopped once the
transient hypothyroidism has resolved. Lastly, prevention
may be the best approach, with consideration of replacing
iodine-containing topical cleansing solutions with effective
alternatives when available.4. Conclusion
Premature infants are at risk of developing transient
hypothyroidism in response to a single, short-term topical
iodine exposure, even in iodine-sufficient geographic areas.
Therefore we advise monitoring of thyroid function in these
infants after iodine exposure, as treatment with levothyr-
oxine may be needed for a limited duration to prevent the
sequelae of untreated hypothyroidism.References
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